Vicarious Surgical Inc (NYSE:RBOT – Get Free Report) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 65,800 shares, a decline of 28.9% from the October 15th total of 92,600 shares. Based on an average trading volume of 18,600 shares, the days-to-cover ratio is currently 3.5 days.
Vicarious Surgical Stock Up 15.0 %
RBOT traded up $1.37 during trading hours on Thursday, reaching $10.52. 60,459 shares of the company’s stock traded hands, compared to its average volume of 25,947. The firm has a market capitalization of $62.07 million, a PE ratio of -0.97 and a beta of 1.02. Vicarious Surgical has a 52-week low of $4.27 and a 52-week high of $21.43. The firm has a 50-day moving average price of $6.95 and a 200 day moving average price of $7.64.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($2.86) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.98) by $0.12. Equities analysts predict that Vicarious Surgical will post -10.07 EPS for the current fiscal year.
Analyst Ratings Changes
Check Out Our Latest Analysis on Vicarious Surgical
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Recommended Stories
- Five stocks we like better than Vicarious Surgical
- The Risks of Owning Bonds
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Breakout Stocks: What They Are and How to Identify Them
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Capture the Benefits of Dividend Increases
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.